Almirall S.A.
Global biopharmaceutical company specializing in medical dermatology and skin health.
ALM | MC
Overview
Corporate Details
- ISIN(s):
- ES0157097017
- LEI:
- 95980020140005007996
- Country:
- Spain
- Address:
- Ronda General Mitre 151, 08022 Barcelona
- Website:
- http://www.almirall.com
- Sector:
- Manufacturing
Description
Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-26 06:56 |
Comisión de Dermatología & Comisión de Nombramientos y Retribuciones
|
Spanish | 27.8 KB | ||
| 2021-07-19 15:00 |
Almirall recibe la aprobación de la Comisión Europea para Klisyri® (tirbanibuli…
|
Spanish | 50.3 KB | ||
| 2021-07-06 17:39 |
Operaciones del contrato de liquidez durante el segundo trimestre de 2021
|
Spanish | 140.8 KB | ||
| 2021-07-01 08:24 |
Almirall y Kaken Pharmaceutical firman un acuerdo de licencia y distribución de…
|
Spanish | 49.7 KB | ||
| 2021-06-29 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2021-06-18 14:35 |
Acuerdos de la Junta General Extraordinaria de Accionistas de la Sociedad
|
Spanish | 71.6 KB | ||
| 2021-06-11 10:58 |
Almirall anuncia el nombramiento de Dr. Karl Ziegelbauer como nuevo Director Ci…
|
Spanish | 48.5 KB | ||
| 2021-06-03 07:55 |
La Sociedad comunica información relativa al dividendo flexible
|
Spanish | 64.7 KB | ||
| 2021-06-03 00:00 |
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | ||
| 2021-05-21 13:35 |
Almirall recibe la opinión positiva del CHMP para Klisyri® (tirbanibulina), un …
|
Spanish | 49.5 KB | ||
| 2021-05-10 07:07 |
Almirall remite presentación sobre los Resultados del primer trimestre de 2021
|
Spanish | 1.3 MB | ||
| 2021-05-07 16:37 |
La Sociedad comunica el calendario del dividendo flexible
|
Spanish | 123.3 KB | ||
| 2021-04-07 17:42 |
Operaciones del contrato de liquidez durante el primer trimestre de 2021
|
Spanish | 139.2 KB | ||
| 2021-03-23 17:33 |
Junta General Ordinaria
|
Spanish | 267.1 KB | ||
| 2021-03-16 08:30 |
Almirall ha decidido no ejercer su derecho de opción para adquirir Bioniz Thera…
|
Spanish | 186.8 KB |
Automate Your Workflow. Get a real-time feed of all Almirall S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Almirall S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Almirall S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
